Axicabtagene Ciloleucel CAR T-cell therapy for relapsed/refractory secondary CNS non-Hodgkin lymphoma: comparable outcomes and toxicities, but shorter remissions may warrant alternative consolidative strategies?
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
12
References
5
Citations
NaN
KQI